Beam Therapeutics Inc.

Developing precision genetic medicines using base editing to provide cures for serious diseases.

BEAM | US

Overview

Corporate Details

ISIN(s):: US07373V1052
LEI:
Country:: United States of America
Address:: 26 LANDSDOWNE STREET, 2139 CAMBRIDGE
Website:: https://beamtx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Beam Therapeutics is a biotechnology company pioneering the development of precision genetic medicines through its proprietary base editing technology. Launched in 2018, the company utilizes a next-generation CRISPR platform designed to make precise, single-letter edits to the genome without creating double-stranded breaks in the DNA. Beam's mission is to provide lifelong cures for patients with serious diseases, focusing on genetic disorders, hematological conditions, and oncology. The company is building a fully integrated platform with a diverse suite of delivery technologies, including viral, nonviral, and electroporation modalities, to advance its portfolio of investigational therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
	2025-11-04 13:11	Quarterly Report 10-Q - Beam Therapeutics Inc. (0001745999) (Filer)	English	1.9 MB
	2025-11-04 13:06	Regulatory News Service 8-K - Beam Therapeutics Inc. (0001745999) (Filer)	English	163.6 KB

Automate Your Workflow. Get a real-time feed of all Beam Therapeutics Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Beam Therapeutics Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Beam Therapeutics Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Quantum Genomics Biopharma developing cardiovascular treatments, now in judicial liquidation.	France	ALQGC
QuidelOrtho Corp Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.	United States of America	QDEL
Quince Therapeutics, Inc. Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.	United States of America	QNCX
Quoin Pharmaceuticals, Ltd. Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.	United States of America	QNRX
Quratis Inc. Develops infectious disease vaccines and offers biologics CDMO services for global health.	South Korea	348080
Radiopharm Theranostics Ltd Developing first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer.	United States of America	RADX
Rallybio Corp Develops therapies for severe and rare diseases in hematology and complement dysregulation.	United States of America	RLYB
Rani Therapeutics Holdings, Inc. Develops a capsule to convert injectable biologics into oral pills for chronic diseases.	United States of America	RANI
Rapport Therapeutics, Inc. Developing precision small molecule medicines for Central Nervous System (CNS) disorders.	United States of America	RAPP
RAPT Therapeutics, Inc. Developing immune-targeting therapies for inflammatory and immunologic diseases.	United States of America	RAPT